Session Details
[28-10-am]Clinical Pharmacy 4, Basics
Sat. Mar 28, 2026 9:30 AM - 11:30 AM JST
Sat. Mar 28, 2026 12:30 AM - 2:30 AM UTC
Sat. Mar 28, 2026 12:30 AM - 2:30 AM UTC
Room 10 (C303, Bldg. 2, Area 2 [3F])
Chair: Manabu Suno, Kenji Okada
[28-10-am01S]In vivo PK/PD Evaluation of Faropenem Against ESBL-Producing Escherichia coli
○Natsuki Satake1, Takuma Muraishi1, Yuki Mizukami1, Mishu Takahashi1, Shintaro Ikegami1, Sho Tashiro1, Yuko Okamoto1, Yuki Igarashi1, Yuki Enoki1, Kazuaki Matsumoto1 (1. Pharm. Keio Univ.)
[28-10-am02S]Evaluation of the preventive effect of ursodeoxycholic acid on disease severity in a mouse model of Clostridioides difficile infection
○Ayu Tsubouchi1, Takayuki Mihara1, Saki Saito1, Yuko Okamoto1, Yuki Igarashi1, Yuki Enoki1, Kazuaki Matsumoto1 (1. Pharm. Keio Univ.)
[28-10-am03S]In vivo PK/PD Evaluation of Amoxicillin/Clavulanic Acid Against ESBL-Producing Escherichia coli
○Takuma Muraishi1, Natsuki Satake1, Yuki Mizukami1, Mishu Takahashi1, Kenta Suzuki1, Takayuki Mihara1, Sho Tashiro1, Yuko Okamoto1, Yuki Igarashi1, Yuki Enoki1, Kazuaki Matsumoto1 (1. Pharm. Keio Univ)
[28-10-am04S]Evaluation of the Anti-inflammatory Effects and the Gut Microbiota of Fidaxomicin Using a Dextran Sodium Sulfate-Induced Inflammatory Bowel Disease Mouse Model
○Takayuki Mihara1, Shintaro Ikegami1, Yuki Igarashi2, Yuki Enoki2, Kazuaki Taguchi3, Kazuaki Matsumoto2 (1. Grad. Sch. Pharm. Sci., Keio Univ., 2. Pharm., Keio Univ., 3. Pharm., Hiroshima Univ.)
[28-10-am05S]Functional analysis of tight junctions in an in vitro human placental model using the JEG3 monolayer system
○Yurina Nagao1, Ryusei Hayashi1, Yuki Niwa2, Kenji Ikeda2, Masuo Kondoh2,3,4 (1. Sch.Pharm.Sci.,UOsaka., 2. Grad.Sch.Pharm.Sci.,UOsaka., 3. CiDER,UOsaka, 4. MEI,UOsaka)
[28-10-am06S]Inflammasome activation and impaired immune tolerance in vildagliptin-induced liver injury
○Serina Mizuguchi1, Saori Tanaka1,2, Rei Aoki2, Takumi Noda1,3, Kazuya Urashima1,4, Ayumi Fujimoto1,5, Mayuko Takaori1,6, Ayaka Kidani1, Jina Suzuki1, Yuka Kohda1,2, Ryuji Kato1,2 (1. Graduate School of Pharmaceutical Sciences, Osaka Medical and Pharmaceutical University, 2. Pharmaceutical Sciences, Osaka Medical and Pharmaceutical University, 3. Department of pharmacy, National Hospital Organization Osaka National Hospital, 4. Department of pharmacy, JCHO Osaka Minato Central Hospital, 5. Department of pharmacy, Osaka City General Hospital, 6. Department of Pharmacy, Kansai Electric Power Hospital)
[28-10-am07]Inhibition of Aβ Aggregation by Chol-PEG Vesicles and Micelles
○Shoichiro Asayama1, Shota Watanabe1, Motoki Ueda1 (1. Dept. of Applied Chem., Tokyo Metropolitan Univ.)
[28-10-am08S]In vitro and in vivo evaluation of the combined effect of metronidazole and fidaxomicin against Clostridioides difficile
○Shintaro Ikegami1, Sho Tashiro1, Takayuki Mihara1, Ayaka Hosoi1, Saki Saito2, Yuki Mizukami1, Yuko Okamoto2, Yuki Igarashi2, Yuki Enoki2, Kazuaki Matsumoto2 (1. Grad. Sch. Pharm. Sci., Keio Univ., 2. Pharm., Keio Univ.)
[28-10-am09]Mirogabalin alleviates bladder pain and hypersensitivity in a rat model of interstitial cystitis/bladder pain syndrome
○Masaru Yoshizumi1, Chizuko Watanabe1, Hirokazu Mizoguchi1 (1. Tohoku Med. Pharm. Univ.)
[28-10-am10S]Renoprotection by the combination of Lactulose and Canagliflozin via Akkermansia muciniphila and elucidation of its mechanism
○Mayu Oki1, Mai Hashimoto2, Risa Obata2, Yuki Narita2, Takashige Kuwabara3, Ebenezer Ofori-Attah1, Hideaki Jinnouchi4, Motoko Tanaka5, Toru Maruyama6, Hideki Yokoi3, Daisuke Kadowaki1,2,7 (1. Grad. Sch. Pharm. Sci., Sojo Univ., 2. Fac. Pharm. Sci., Sojo Univ., 3. Fac. Med., Kumamoto Univ., 4. Jinnouchi Hosp., 5. Akebono Clin., 6. Fac. Pharm. Sci., Kumamoto Univ., 7. DDS Res. Inst., Sojo Univ.)